| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.30e-06 | 12 | 146 | 4 | GO:0032396 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 3.79e-06 | 5 | 146 | 3 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 7.54e-06 | 6 | 146 | 3 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 7.75e-06 | 18 | 146 | 4 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 1.31e-05 | 7 | 146 | 3 | GO:0023025 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.41e-05 | 149 | 146 | 8 | GO:1990782 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.47e-05 | 210 | 146 | 9 | GO:0019903 | |
| GeneOntologyMolecularFunction | IgM binding | 6.05e-05 | 11 | 146 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.31e-04 | 14 | 146 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.35e-04 | 36 | 146 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.44e-04 | 264 | 146 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.61e-04 | 70 | 146 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 2.00e-04 | 16 | 146 | 3 | GO:0023029 | |
| GeneOntologyMolecularFunction | oxoglutarate dehydrogenase (succinyl-transferring) activity | 3.16e-04 | 4 | 146 | 2 | GO:0004591 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 3.41e-04 | 19 | 146 | 3 | GO:0032394 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 5.23e-04 | 5 | 146 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.65e-04 | 52 | 146 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 6.06e-04 | 196 | 146 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.09e-04 | 23 | 146 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | MHC protein binding | 8.57e-04 | 58 | 146 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.20e-03 | 161 | 146 | 6 | GO:0019842 | |
| GeneOntologyMolecularFunction | filamin binding | 1.22e-03 | 29 | 146 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.22e-03 | 29 | 146 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.36e-03 | 165 | 146 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | thiamine pyrophosphate binding | 1.44e-03 | 8 | 146 | 2 | GO:0030976 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.63e-03 | 32 | 146 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 1.85e-03 | 9 | 146 | 2 | GO:0016624 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 1.85e-03 | 9 | 146 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.92e-03 | 72 | 146 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.94e-03 | 34 | 146 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 2.11e-03 | 35 | 146 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | very long-chain fatty acid-CoA ligase activity | 2.30e-03 | 10 | 146 | 2 | GO:0031957 | |
| GeneOntologyMolecularFunction | phospholipid binding | AGAP5 PSG1 APOB AGAP11 CEACAM1 PITPNM1 PEMT SNX27 PSG8 AGAP9 MTSS2 | 2.35e-03 | 548 | 146 | 11 | GO:0005543 |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 8.08e-07 | 11 | 148 | 4 | GO:0140105 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 2.63e-06 | 85 | 148 | 7 | GO:0002762 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 4.06e-06 | 59 | 148 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 1.36e-05 | 151 | 148 | 8 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.98e-05 | 159 | 148 | 8 | GO:1903707 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 2.06e-05 | 116 | 148 | 7 | GO:0045670 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 2.26e-05 | 162 | 148 | 8 | GO:0030316 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.95e-05 | 83 | 148 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 5.19e-05 | 182 | 148 | 8 | GO:0002761 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 5.21e-05 | 134 | 148 | 7 | GO:0045638 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 6.72e-05 | 96 | 148 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 8.28e-05 | 62 | 148 | 5 | GO:0035306 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 8.86e-05 | 33 | 148 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.23e-04 | 107 | 148 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.24e-04 | 14 | 148 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 1.24e-04 | 14 | 148 | 3 | GO:1900454 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.55e-04 | 15 | 148 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.55e-04 | 15 | 148 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.55e-04 | 15 | 148 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.55e-04 | 15 | 148 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.89e-04 | 16 | 148 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.90e-04 | 40 | 148 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.99e-04 | 166 | 148 | 7 | GO:0002698 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.10e-04 | 41 | 148 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.29e-04 | 17 | 148 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.29e-04 | 17 | 148 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.29e-04 | 17 | 148 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.73e-04 | 18 | 148 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 2.75e-04 | 124 | 148 | 6 | GO:0050672 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | ERBB2 LILRA1 LILRA2 ZNF609 PSG1 FOS ZFPM1 LILRB1 CEACAM1 PSG8 PHF10 | 2.76e-04 | 429 | 148 | 11 | GO:1902105 |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 2.99e-04 | 126 | 148 | 6 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.02e-04 | 45 | 148 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | receptor internalization | 3.49e-04 | 182 | 148 | 7 | GO:0031623 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 3.57e-04 | 47 | 148 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.77e-04 | 20 | 148 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 3.88e-04 | 86 | 148 | 5 | GO:0042058 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.10e-04 | 187 | 148 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 4.16e-04 | 134 | 148 | 6 | GO:0070664 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 4.20e-04 | 49 | 148 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 4.31e-04 | 312 | 148 | 9 | GO:0002573 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.38e-04 | 21 | 148 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 4.38e-04 | 21 | 148 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 4.38e-04 | 21 | 148 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 5.04e-04 | 22 | 148 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 5.06e-04 | 139 | 148 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 5.27e-04 | 52 | 148 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 5.56e-04 | 93 | 148 | 5 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.77e-04 | 23 | 148 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 5.77e-04 | 23 | 148 | 3 | GO:1900452 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.77e-04 | 23 | 148 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | ERBB2 LILRA1 RIN3 LILRA2 PSG1 ZFPM1 CR2 CBLB LILRB1 SVEP1 CEACAM1 PSG8 ZPBP2 | 6.36e-04 | 631 | 148 | 13 | GO:0002683 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 6.56e-04 | 24 | 148 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 6.56e-04 | 24 | 148 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 6.56e-04 | 24 | 148 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 ERBB2 ZNF609 PSG1 PCDHGB2 CLEC7A SIRPB1 ITGA1 CBLB LILRB1 SVEP1 CEACAM1 PKD1 PCDHGB4 UMOD PSG8 ZP4 PHF10 | 7.23e-04 | 1077 | 148 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 7.42e-04 | 25 | 148 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 7.42e-04 | 25 | 148 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell cortex | 7.53e-04 | 6 | 148 | 2 | GO:1904778 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | ERBB2 ZNF609 PSG1 SIRPB1 CBLB LILRB1 CEACAM1 UMOD PSG8 ZP4 PHF10 | 7.83e-04 | 486 | 148 | 11 | GO:0007159 |
| GeneOntologyBiologicalProcess | circulatory system process | KCNMB2 ADCY10 IRX5 PSG1 ITGA1 SVEP1 CRHR2 CEACAM1 SLC44A1 SLC16A1 SCN4A UMOD PSG8 GNAI3 | 8.25e-04 | 733 | 148 | 14 | GO:0003013 |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 9.09e-04 | 60 | 148 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 9.33e-04 | 27 | 148 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 9.67e-04 | 61 | 148 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 1.04e-03 | 353 | 148 | 9 | GO:0010721 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 1.04e-03 | 28 | 148 | 3 | GO:0043011 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.04e-03 | 28 | 148 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.06e-03 | 160 | 148 | 6 | GO:0038127 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.04e-06 | 90 | 151 | 7 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 7.13e-06 | 98 | 151 | 7 | GO:0060170 | |
| GeneOntologyCellularComponent | cell projection membrane | ERBB2 SLC17A3 PSG1 CUBN PTCH1 ADCY3 CEACAM1 DLC1 PEMT PKD1 UMOD PSG8 MTSS2 | 1.55e-05 | 431 | 151 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 3.01e-05 | 9 | 151 | 3 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 7.75e-05 | 12 | 151 | 3 | GO:0032997 | |
| GeneOntologyCellularComponent | basal part of cell | ADCY10 SLC43A2 ERBB2 CNNM2 PSG1 ITGA1 CEACAM1 SLC16A1 PKD1 UMOD PSG8 | 9.81e-05 | 378 | 151 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.93e-04 | 16 | 151 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | side of membrane | LYPD4 LILRA1 LILRA2 PSG1 CLEC7A ITGA1 CUBN CR2 LILRB1 CEACAM1 TEX101 UMOD CCR4 GNAI1 PSG8 GNAI3 MTSS2 | 2.02e-04 | 875 | 151 | 17 | GO:0098552 |
| GeneOntologyCellularComponent | apical part of cell | ADCY10 ERBB2 SORBS2 SLC17A3 PSG1 CUBN PTCH1 MFRP CEACAM1 SLC16A1 UMOD GPSM2 PSG8 | 3.74e-04 | 592 | 151 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.44e-04 | 320 | 151 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | apical plasma membrane | ADCY10 ERBB2 SORBS2 SLC17A3 PSG1 CUBN MFRP CEACAM1 SLC16A1 UMOD PSG8 | 8.43e-04 | 487 | 151 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | central region of growth cone | 1.06e-03 | 7 | 151 | 2 | GO:0090724 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.11e-03 | 354 | 151 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | external side of plasma membrane | LILRA1 LILRA2 PSG1 CLEC7A ITGA1 CUBN CR2 LILRB1 CEACAM1 CCR4 PSG8 | 1.41e-03 | 519 | 151 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | plasma membrane protein complex | KCNMB2 TRAV9-2 ERBB2 LILRA1 LILRA2 PSG1 ITGA1 LILRB1 CEACAM1 SCN4A GNAI1 PSG8 GNAI3 TRAV18 | 1.69e-03 | 785 | 151 | 14 | GO:0098797 |
| Domain | Ig_2 | 9.54e-08 | 73 | 145 | 8 | PF13895 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 9.01e-06 | 6 | 145 | 3 | IPR016332 | |
| Domain | 2-oxogl_dehyd_N | 5.99e-05 | 2 | 145 | 2 | IPR032106 | |
| Domain | 2-oxogl_dehyd_N | 5.99e-05 | 2 | 145 | 2 | PF16078 | |
| Domain | IGc2 | 9.33e-05 | 235 | 145 | 9 | SM00408 | |
| Domain | Ig_sub2 | 9.33e-05 | 235 | 145 | 9 | IPR003598 | |
| Domain | PMG | 1.24e-04 | 13 | 145 | 3 | PF05287 | |
| Domain | KRTAP_PMG | 1.24e-04 | 13 | 145 | 3 | IPR007951 | |
| Domain | 2oxoglutarate_DH_E1 | 1.79e-04 | 3 | 145 | 2 | IPR011603 | |
| Domain | KGD_C | 1.79e-04 | 3 | 145 | 2 | IPR031717 | |
| Domain | OxoGdeHyase_C | 1.79e-04 | 3 | 145 | 2 | PF16870 | |
| Domain | - | LILRA1 LILRA3 LILRA2 PTCRA PSG1 SIRPB1 PKHD1L1 LILRB1 TRIM3 CEACAM1 WFIKKN2 CLMP PSG8 ZPBP2 HCFC2 | 2.04e-04 | 663 | 145 | 15 | 2.60.40.10 |
| Domain | RetinoicA-induced_16-like | 3.56e-04 | 4 | 145 | 2 | IPR019384 | |
| Domain | RAI16-like | 3.56e-04 | 4 | 145 | 2 | PF10257 | |
| Domain | REJ | 3.56e-04 | 4 | 145 | 2 | PS51111 | |
| Domain | REJ_dom | 3.56e-04 | 4 | 145 | 2 | IPR014010 | |
| Domain | Ig-like_fold | LILRA1 LILRA3 LILRA2 PTCRA PSG1 SIRPB1 PKHD1L1 LILRB1 TRIM3 CEACAM1 WFIKKN2 CLMP PSG8 ZPBP2 HCFC2 | 3.97e-04 | 706 | 145 | 15 | IPR013783 |
| Domain | Ig-like_dom | LILRA1 LILRA3 LILRA2 PTCRA PSG1 SIRPB1 LILRB1 CEACAM1 WFIKKN2 CLMP PSG8 ZPBP2 | 5.65e-04 | 503 | 145 | 12 | IPR007110 |
| Domain | ig | 7.16e-04 | 190 | 145 | 7 | PF00047 | |
| Domain | Immunoglobulin | 7.16e-04 | 190 | 145 | 7 | IPR013151 | |
| Domain | E1_dh | 8.80e-04 | 6 | 145 | 2 | PF00676 | |
| Domain | DH_E1 | 8.80e-04 | 6 | 145 | 2 | IPR001017 | |
| Domain | PKD/REJ-like | 8.80e-04 | 6 | 145 | 2 | IPR002859 | |
| Domain | REJ | 8.80e-04 | 6 | 145 | 2 | PF02010 | |
| Domain | ArfGap | 1.44e-03 | 29 | 145 | 3 | SM00105 | |
| Domain | ARFGAP | 1.44e-03 | 29 | 145 | 3 | PS50115 | |
| Domain | ArfGap | 1.44e-03 | 29 | 145 | 3 | PF01412 | |
| Domain | ArfGAP | 1.44e-03 | 29 | 145 | 3 | IPR001164 | |
| Domain | Gprotein_alpha_I | 1.63e-03 | 8 | 145 | 2 | IPR001408 | |
| Domain | Transketolase-like_Pyr-bd | 1.63e-03 | 8 | 145 | 2 | IPR005475 | |
| Domain | VPS9 | 1.63e-03 | 8 | 145 | 2 | SM00167 | |
| Domain | Transket_pyr | 1.63e-03 | 8 | 145 | 2 | SM00861 | |
| Domain | Transket_pyr | 1.63e-03 | 8 | 145 | 2 | PF02779 | |
| Domain | IG | LILRA1 LILRA3 LILRA2 PSG1 SIRPB1 LILRB1 CEACAM1 WFIKKN2 CLMP PSG8 | 1.68e-03 | 421 | 145 | 10 | SM00409 |
| Domain | Ig_sub | LILRA1 LILRA3 LILRA2 PSG1 SIRPB1 LILRB1 CEACAM1 WFIKKN2 CLMP PSG8 | 1.68e-03 | 421 | 145 | 10 | IPR003599 |
| Domain | GPS | 2.30e-03 | 34 | 145 | 3 | SM00303 | |
| Domain | Anoctamin | 2.59e-03 | 10 | 145 | 2 | PF04547 | |
| Domain | Anoctamin | 2.59e-03 | 10 | 145 | 2 | IPR007632 | |
| Domain | VPS9 | 2.59e-03 | 10 | 145 | 2 | PS51205 | |
| Domain | VPS9 | 2.59e-03 | 10 | 145 | 2 | PF02204 | |
| Domain | VPS9 | 2.59e-03 | 10 | 145 | 2 | IPR003123 | |
| Domain | ZP_dom_CS | 2.59e-03 | 10 | 145 | 2 | IPR017977 | |
| Domain | GPS | 2.94e-03 | 37 | 145 | 3 | IPR000203 | |
| Domain | GFP-like | 3.14e-03 | 11 | 145 | 2 | IPR023413 | |
| Domain | Ephrin_rec_like | 3.14e-03 | 11 | 145 | 2 | PF07699 | |
| Domain | DUF1220 | 3.14e-03 | 11 | 145 | 2 | PF06758 | |
| Domain | - | 3.14e-03 | 11 | 145 | 2 | 2.40.155.10 | |
| Domain | PKD_channel | 3.14e-03 | 11 | 145 | 2 | PF08016 | |
| Domain | NBPF_dom | 3.14e-03 | 11 | 145 | 2 | IPR010630 | |
| Domain | NBPF | 3.14e-03 | 11 | 145 | 2 | PS51316 | |
| Domain | PKD1_2_channel | 3.14e-03 | 11 | 145 | 2 | IPR013122 | |
| Domain | EGF_dom | 3.75e-03 | 12 | 145 | 2 | IPR024731 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.75e-03 | 12 | 145 | 2 | IPR011041 | |
| Domain | EGF_3 | 3.75e-03 | 12 | 145 | 2 | PF12947 | |
| Domain | THDP-binding | 4.41e-03 | 13 | 145 | 2 | IPR029061 | |
| Domain | - | 4.41e-03 | 13 | 145 | 2 | 3.40.50.970 | |
| Domain | IG_LIKE | LILRA1 LILRA3 LILRA2 PSG1 SIRPB1 LILRB1 CEACAM1 WFIKKN2 CLMP PSG8 | 5.04e-03 | 491 | 145 | 10 | PS50835 |
| Domain | ZP_2 | 5.12e-03 | 14 | 145 | 2 | PS51034 | |
| Domain | ZP_1 | 5.12e-03 | 14 | 145 | 2 | PS00682 | |
| Domain | Glyco_hormone_CN | 5.88e-03 | 15 | 145 | 2 | IPR006208 | |
| Domain | Cys_knot | 5.88e-03 | 15 | 145 | 2 | PF00007 | |
| Domain | ZP | 5.88e-03 | 15 | 145 | 2 | SM00241 | |
| Domain | GproteinA_insert | 6.69e-03 | 16 | 145 | 2 | IPR011025 | |
| Domain | - | 6.69e-03 | 16 | 145 | 2 | 1.10.400.10 | |
| Domain | G-alpha | 6.69e-03 | 16 | 145 | 2 | PF00503 | |
| Domain | G_alpha | 6.69e-03 | 16 | 145 | 2 | SM00275 | |
| Domain | Growth_fac_rcpt_ | 7.45e-03 | 156 | 145 | 5 | IPR009030 | |
| Domain | Gprotein_alpha_su | 7.54e-03 | 17 | 145 | 2 | IPR001019 | |
| Domain | ZP_dom | 7.54e-03 | 17 | 145 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 7.54e-03 | 17 | 145 | 2 | PF00100 | |
| Domain | Sushi | 7.67e-03 | 52 | 145 | 3 | PF00084 | |
| Pubmed | 2.42e-08 | 8 | 152 | 4 | 9548455 | ||
| Pubmed | 1.13e-07 | 11 | 152 | 4 | 20145200 | ||
| Pubmed | 1.37e-07 | 54 | 152 | 6 | 8482578 | ||
| Pubmed | Plasticity in the organization and sequences of human KIR/ILT gene families. | 3.26e-07 | 4 | 152 | 3 | 10781084 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 21559424 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 3.26e-07 | 4 | 152 | 3 | 21270408 | |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 3.39e-07 | 14 | 152 | 4 | 14993377 | |
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 8.13e-07 | 5 | 152 | 3 | 18787130 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 27443384 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 8.13e-07 | 5 | 152 | 3 | 15494528 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 37146940 | ||
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 8.13e-07 | 5 | 152 | 3 | 24302763 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 23927735 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 21087927 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 20398663 | ||
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 8.13e-07 | 5 | 152 | 3 | 22948046 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 9054430 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 27324131 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 8.13e-07 | 5 | 152 | 3 | 25075127 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 8.13e-07 | 5 | 152 | 3 | 16011512 | |
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 8.13e-07 | 5 | 152 | 3 | 12403357 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 34242819 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 20976309 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 20881122 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 19684158 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 8.13e-07 | 5 | 152 | 3 | 34120891 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 8.13e-07 | 5 | 152 | 3 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 8.13e-07 | 5 | 152 | 3 | 33653799 | |
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 8.13e-07 | 5 | 152 | 3 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 8.13e-07 | 5 | 152 | 3 | 23152562 | |
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 8.13e-07 | 5 | 152 | 3 | 10359805 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 10586026 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 8.13e-07 | 5 | 152 | 3 | 22102155 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 23258232 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 1.62e-06 | 6 | 152 | 3 | 12207326 | |
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 9824165 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 38383888 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 39095838 | ||
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 1.62e-06 | 6 | 152 | 3 | 18768880 | |
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 1.62e-06 | 6 | 152 | 3 | 37481670 | |
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 31727773 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 30787106 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 9079806 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 21636572 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 24040397 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 30068593 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 28664612 | ||
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 1.62e-06 | 6 | 152 | 3 | 27752542 | |
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 1.62e-06 | 6 | 152 | 3 | 18988857 | |
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 27402837 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 1.62e-06 | 6 | 152 | 3 | 21881600 | |
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 1.62e-06 | 6 | 152 | 3 | 12021780 | |
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 15146181 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 29482582 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 25320232 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 30975754 | ||
| Pubmed | 1.62e-06 | 6 | 152 | 3 | 24212998 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 17998301 | ||
| Pubmed | Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. | 2.83e-06 | 7 | 152 | 3 | 17371981 | |
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 2.83e-06 | 7 | 152 | 3 | 19658091 | |
| Pubmed | The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling. | 2.83e-06 | 7 | 152 | 3 | 24278366 | |
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 36510132 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 19687229 | ||
| Pubmed | PirB restricts ocular-dominance plasticity in visual cortex. | 2.83e-06 | 7 | 152 | 3 | 16917027 | |
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 35321392 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 20844138 | ||
| Pubmed | Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. | 2.83e-06 | 7 | 152 | 3 | 21555536 | |
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 2.83e-06 | 7 | 152 | 3 | 18316626 | |
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 27897222 | ||
| Pubmed | 4.51e-06 | 8 | 152 | 3 | 18209065 | ||
| Pubmed | NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation. | 4.51e-06 | 8 | 152 | 3 | 24449409 | |
| Pubmed | Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. | 4.51e-06 | 8 | 152 | 3 | 22660330 | |
| Pubmed | 4.51e-06 | 8 | 152 | 3 | 21376641 | ||
| Pubmed | 4.51e-06 | 8 | 152 | 3 | 19255189 | ||
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 4.51e-06 | 8 | 152 | 3 | 9538215 | |
| Pubmed | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | 4.51e-06 | 8 | 152 | 3 | 35210567 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 5.67e-06 | 218 | 152 | 8 | 33378226 | |
| Pubmed | 6.62e-06 | 28 | 152 | 4 | 8672132 | ||
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 6.74e-06 | 9 | 152 | 3 | 38651641 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 6.74e-06 | 9 | 152 | 3 | 12640130 | |
| Pubmed | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. | 6.74e-06 | 9 | 152 | 3 | 17420263 | |
| Pubmed | PIRs mediate innate myeloid cell memory to nonself MHC molecules. | 9.60e-06 | 10 | 152 | 3 | 32381589 | |
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 9.60e-06 | 10 | 152 | 3 | 18802077 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 9.60e-06 | 10 | 152 | 3 | 22973535 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 9.60e-06 | 10 | 152 | 3 | 20664521 | |
| Pubmed | 9.60e-06 | 10 | 152 | 3 | 26755700 | ||
| Pubmed | AGAP5 CNNM2 LRRTM3 SIRPB1 AGAP11 ADCY3 TRIM3 SLC44A1 GNAI1 AGAP9 | 1.27e-05 | 405 | 152 | 10 | 38187761 | |
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 24738827 | ||
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 24052308 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.32e-05 | 11 | 152 | 3 | 15381706 | |
| Pubmed | Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. | 1.32e-05 | 11 | 152 | 3 | 21364532 | |
| Pubmed | 1.75e-05 | 12 | 152 | 3 | 22445338 | ||
| Pubmed | Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. | 1.75e-05 | 12 | 152 | 3 | 10611342 | |
| Pubmed | Gene order and genetic distance of 13 loci spanning murine chromosome 15. | 1.75e-05 | 12 | 152 | 3 | 1358803 | |
| Pubmed | Signaling pathways for modulation of mouse sperm motility by adenosine and catecholamine agonists. | 1.90e-05 | 2 | 152 | 2 | 16291925 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 29511113 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 18492727 | ||
| Cytoband | 19q13.4 | 1.43e-04 | 79 | 152 | 4 | 19q13.4 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | ERBB2 LILRA1 LILRA3 LILRA2 PSG1 CLEC7A SIRPB1 ITGA1 CR2 LILRB1 CEACAM1 SLC44A1 CCR4 | 5.83e-07 | 394 | 107 | 13 | 471 |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 3.98e-06 | 6 | 107 | 3 | 1181 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.29e-04 | 17 | 107 | 3 | 1291 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.27e-04 | 23 | 107 | 3 | 662 | |
| GeneFamily | ArfGAPs | 9.66e-04 | 33 | 107 | 3 | 395 | |
| GeneFamily | Anoctamins | 1.51e-03 | 10 | 107 | 2 | 865 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.51e-03 | 10 | 107 | 2 | 53 | |
| GeneFamily | VPS9 domain containing | 1.51e-03 | 10 | 107 | 2 | 928 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.84e-03 | 11 | 107 | 2 | 1315 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.68e-03 | 57 | 107 | 3 | 1179 | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SLC43A2 TET2 DMXL2 LILRA1 LILRA2 CLEC7A SIRPB1 LILRB1 NBPF14 | 3.07e-08 | 200 | 152 | 9 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 |
| ToppCell | Biopsy_Other_PF-Immune-Monocytes|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.07e-08 | 200 | 152 | 9 | 83bca55d48aae8885deb83e15b2684910e4c3358 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-07 | 189 | 152 | 8 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-07 | 189 | 152 | 8 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-07 | 194 | 152 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 3.71e-07 | 195 | 152 | 8 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 3.86e-07 | 196 | 152 | 8 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-07 | 196 | 152 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-07 | 197 | 152 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-07 | 197 | 152 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.01e-07 | 197 | 152 | 8 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-07 | 197 | 152 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-07 | 198 | 152 | 8 | 7015b9f5ead65937e056d746340d44d0655d6a3e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-07 | 198 | 152 | 8 | 6edf6c547e8a3aa2b23df4662bf59ed38caa9e5e | |
| ToppCell | healthy_donor-Myeloid|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.33e-07 | 199 | 152 | 8 | d41994e08f7c3f5bd865b689db8f032efbe88d24 | |
| ToppCell | healthy_donor-Myeloid-Monocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.33e-07 | 199 | 152 | 8 | bd66a8d1a7cc92313328acc7c7ae0442faff951e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-07 | 199 | 152 | 8 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-07 | 200 | 152 | 8 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.49e-07 | 200 | 152 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.49e-07 | 200 | 152 | 8 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-07 | 200 | 152 | 8 | 47abc2ebf5d6575af59aa044b584acf63a463bbb | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-07 | 200 | 152 | 8 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | Biopsy_IPF-Immune-Monocytes|Biopsy_IPF / Sample group, Lineage and Cell type | 4.49e-07 | 200 | 152 | 8 | 80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.98e-06 | 170 | 152 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 178 | 152 | 7 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 3.00e-06 | 181 | 152 | 7 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-06 | 187 | 152 | 7 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-06 | 187 | 152 | 7 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 4.00e-06 | 189 | 152 | 7 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 189 | 152 | 7 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.14e-06 | 190 | 152 | 7 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 191 | 152 | 7 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-06 | 191 | 152 | 7 | 1c7d31684654ca6a046d8cc816af1fdc42369c57 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-06 | 191 | 152 | 7 | d60d81d2045c6e624bbc8b17e13a32f7921d969f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-06 | 192 | 152 | 7 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-06 | 192 | 152 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-06 | 192 | 152 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 4.43e-06 | 192 | 152 | 7 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.43e-06 | 192 | 152 | 7 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-06 | 192 | 152 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 4.59e-06 | 193 | 152 | 7 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.59e-06 | 193 | 152 | 7 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.74e-06 | 194 | 152 | 7 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-06 | 194 | 152 | 7 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-06 | 194 | 152 | 7 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-06 | 194 | 152 | 7 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-06 | 194 | 152 | 7 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-06 | 194 | 152 | 7 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 195 | 152 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-06 | 196 | 152 | 7 | 5842d6fa0c066815d7d8c7e59b192bfc72960707 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.07e-06 | 196 | 152 | 7 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 5.07e-06 | 196 | 152 | 7 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-06 | 196 | 152 | 7 | 8608be3c3e7fd776c5f2fae207cd0b801e138349 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-06 | 197 | 152 | 7 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.25e-06 | 197 | 152 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.25e-06 | 197 | 152 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-06 | 197 | 152 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 5.25e-06 | 197 | 152 | 7 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-06 | 197 | 152 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 197 | 152 | 7 | d9978aaa476b57144b0561f535ff1dd886c7512b | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 5.25e-06 | 197 | 152 | 7 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Nonclassical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 5.25e-06 | 197 | 152 | 7 | dcf1e74b7c21466d38d68f44d404bce14ade2805 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-06 | 197 | 152 | 7 | c6e977adb1248957d31300312310e08238b64236 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.42e-06 | 198 | 152 | 7 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-06 | 198 | 152 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.42e-06 | 198 | 152 | 7 | a8338da2477ccf8e3d924de8dbe1056b98111532 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-06 | 198 | 152 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.42e-06 | 198 | 152 | 7 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.42e-06 | 198 | 152 | 7 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.42e-06 | 198 | 152 | 7 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.42e-06 | 198 | 152 | 7 | e6dad9dea8cbd368b1b127572212cc913b909ffe | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic|Liver / Manually curated celltypes from each tissue | 5.42e-06 | 198 | 152 | 7 | d0925948bf667545fb0b343e2fc80f7379e433e3 | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic|blood / Manually curated celltypes from each tissue | 5.42e-06 | 198 | 152 | 7 | c0985fff359c78d0fc1b6f31885aa168c9f5fdae | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.42e-06 | 198 | 152 | 7 | bf5806424be33790f78f1c160398046a8725e469 | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.42e-06 | 198 | 152 | 7 | 603846129560d5d6e6df27d6168f67f592e5e6e2 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 5.42e-06 | 198 | 152 | 7 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.61e-06 | 199 | 152 | 7 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.61e-06 | 199 | 152 | 7 | 02256d86541be6851634283047fdc05fdf095114 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 5.61e-06 | 199 | 152 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Non-cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.61e-06 | 199 | 152 | 7 | 969f66a9adb337fa9857fb00bcace2d30c35a6a5 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic|bone_marrow / Manually curated celltypes from each tissue | 5.61e-06 | 199 | 152 | 7 | 62b0861faf173eead75678aad10d396cd0d80c2c | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic-Classical_monocytes|Liver / Manually curated celltypes from each tissue | 5.61e-06 | 199 | 152 | 7 | 46491e8e76aa4d7ada036946f93cf71609c85462 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.61e-06 | 199 | 152 | 7 | 27667838e065370d4536eaaf5b42ad322a714b96 | |
| ToppCell | COVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class | 5.61e-06 | 199 | 152 | 7 | d0c230c3699955a80630b63ed18c770444c5dfe5 | |
| ToppCell | COVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class | 5.61e-06 | 199 | 152 | 7 | babbf3220cc811a1794032e06c6cec4dfc7bff2f | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 5.61e-06 | 199 | 152 | 7 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-06 | 199 | 152 | 7 | cefc3b50f65e95da850e4720c7b44bf584073491 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-06 | 199 | 152 | 7 | aaa460c389cd6d38a13ba1a446f91a94f9573ad8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.79e-06 | 200 | 152 | 7 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | d39bf03817b76c9dfcbcd868341b51bb8601ea9b | |
| ToppCell | severe-Classical_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.79e-06 | 200 | 152 | 7 | ce03be0ccfc22eb923302a2ad73b39752e888270 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid|COVID-19_Severe / Disease, condition lineage and cell class | 5.79e-06 | 200 | 152 | 7 | 1315bc0582b19c2fed91c740a1a7e9285c700df1 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1_high|Severe / Condition, Lineage, Cell class and cell subclass | 5.79e-06 | 200 | 152 | 7 | 449623d6786e30d493f68156b3f1ee8caf9265a6 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 1aa4197f1c7c099313dc2e1f8b1153252add7a33 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid|COVID-19_Mild / Disease, condition lineage and cell class | 5.79e-06 | 200 | 152 | 7 | 247040492b3c327f4144fc94cf210dc04eecc7b0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.79e-06 | 200 | 152 | 7 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.79e-06 | 200 | 152 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.79e-06 | 200 | 152 | 7 | c58a5dc0a0d74a21ca15ee8b7a0197de32afa045 | |
| Computational | Neighborhood of TNFRSF1B | 8.61e-05 | 65 | 75 | 5 | GNF2_TNFRSF1B | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.22e-05 | 10 | 140 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 2.24e-05 | 2 | 140 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 4.56e-05 | 15 | 140 | 3 | EFO_0008208 | |
| Disease | Olmsted syndrome | 6.68e-05 | 3 | 140 | 2 | C2609071 | |
| Disease | cD177 antigen measurement | 8.10e-05 | 18 | 140 | 3 | EFO_0021866 | |
| Disease | asthma, cardiovascular disease | 3.86e-04 | 30 | 140 | 3 | EFO_0000319, MONDO_0004979 | |
| Disease | marginal zone B-cell lymphoma | 6.14e-04 | 8 | 140 | 2 | EFO_1000630 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 6.14e-04 | 8 | 140 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | common bile duct neoplasm (is_marker_for) | 6.14e-04 | 8 | 140 | 2 | DOID:4608 (is_marker_for) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.55e-04 | 145 | 140 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | nitric oxide exhalation measurement | 7.81e-04 | 38 | 140 | 3 | EFO_0005536 | |
| Disease | hepatocellular carcinoma | 9.77e-04 | 41 | 140 | 3 | EFO_0000182 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 9.81e-04 | 10 | 140 | 2 | EFO_0008321 | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0801494 | |
| Disease | Anxiety States, Neurotic | 1.20e-03 | 44 | 140 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 1.20e-03 | 44 | 140 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 1.20e-03 | 44 | 140 | 3 | C0003469 | |
| Disease | homocysteine measurement | 1.37e-03 | 46 | 140 | 3 | EFO_0004578 | |
| Disease | tumor necrosis factor-alpha measurement | 1.64e-03 | 49 | 140 | 3 | EFO_0004684 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 1.84e-03 | 51 | 140 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | visceral:abdominal adipose tissue ratio measurement | 1.95e-03 | 52 | 140 | 3 | EFO_0803318 | |
| Disease | 3-hydroxyanthranilic acid measurement | 2.25e-03 | 15 | 140 | 2 | EFO_0010447 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 2.25e-03 | 15 | 140 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | uric acid measurement | 2.60e-03 | 610 | 140 | 9 | EFO_0004761 | |
| Disease | Tactile Amnesia | 2.90e-03 | 17 | 140 | 2 | C0750906 | |
| Disease | Amnestic State | 2.90e-03 | 17 | 140 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 2.90e-03 | 17 | 140 | 2 | C0236795 | |
| Disease | Hysterical amnesia | 2.90e-03 | 17 | 140 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 2.90e-03 | 17 | 140 | 2 | C0233796 | |
| Disease | Amnesia | 2.90e-03 | 17 | 140 | 2 | C0002622 | |
| Disease | Global Amnesia | 2.90e-03 | 17 | 140 | 2 | C0262497 | |
| Disease | Sjogren syndrome | 2.94e-03 | 60 | 140 | 3 | EFO_0000699 | |
| Disease | food allergy measurement, parental genotype effect measurement | 3.25e-03 | 18 | 140 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | mean platelet volume | SLC43A2 TET2 RIN3 SETD1B PTCRA PCDHGB2 ATG14 SIRPB1 SVEP1 CPEB4 PCDHGB4 CELA1 | 3.47e-03 | 1020 | 140 | 12 | EFO_0004584 |
| Disease | sucrose liking measurement | 4.02e-03 | 20 | 140 | 2 | EFO_0010157 | |
| Disease | colorectal adenoma (is_marker_for) | 4.02e-03 | 20 | 140 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | reticulocyte count | SLC43A2 CNNM2 PSG1 E2F2 ITGA1 ZFPM1 ADCY3 ACSBG1 TBK1 CPEB4 PKD1 PCDHGB4 | 4.21e-03 | 1045 | 140 | 12 | EFO_0007986 |
| Disease | reticulocyte measurement | SLC43A2 CNNM2 PSG1 E2F2 ITGA1 ZFPM1 ADCY3 CDC37L1 ACSBG1 TBK1 CPEB4 PCDHGB4 | 4.47e-03 | 1053 | 140 | 12 | EFO_0010700 |
| Disease | apolipoprotein B measurement | 4.48e-03 | 663 | 140 | 9 | EFO_0004615 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTACPYNYLSTDVGS | 296 | P04626 | |
| YSNLPNYLLGSLSTD | 971 | Q8NDM7 | |
| LCSNGVLTYYSSLGD | 146 | Q8TF27 | |
| TLCSNGVLTYYSSLG | 351 | Q5VTM2 | |
| PQLSCLQSYGSVSYT | 221 | A6NCI8 | |
| QSNPAYTISAALCYA | 296 | Q6ZNE5 | |
| YTLPCSSGYRGNITA | 271 | Q5T601 | |
| YCGLLQIYSADTPSS | 331 | P51679 | |
| TLAGCISTRSYQPKY | 286 | O95388 | |
| IPSYCLGTYCNSASA | 766 | Q8TDJ6 | |
| SQYPLQSLLTGYQCS | 21 | Q9NZJ0 | |
| GSTPSYYQLSNLLAD | 1321 | Q9Y4B4 | |
| TCDSVTYNGSNLPAY | 426 | Q96PN6 | |
| EEQSLLSTYELPSCY | 401 | Q8N865 | |
| SAQSYSGSPYLDLSL | 451 | Q7L5Y6 | |
| PAISSGAIYLASSYQ | 1876 | O14578 | |
| ALLLSYLGECGSSSY | 241 | Q6UXT9 | |
| SLPCLAQSYAYSKSL | 36 | Q9BYT9 | |
| YSCPSVSYSSDLPAT | 111 | Q8N428 | |
| TSAGNSNPYLPYSCE | 186 | Q5RL73 | |
| SPLTICYPEYAGSNT | 281 | P63096 | |
| CLYQYIDSAGLSSVP | 311 | Q9NV88 | |
| PSASLALYSCPAYST | 11 | P78411 | |
| ALYSCPAYSTSVISG | 16 | P78411 | |
| YSGSPANLAVYTALL | 141 | P34897 | |
| YSEGTLPYSYNLCVA | 741 | Q9UN71 | |
| YEGLCQTLGSQPTLY | 301 | Q7Z4N8 | |
| GTYRCYSSLSSNPYL | 391 | Q8N149 | |
| GYVSLFSCVYPLAAA | 506 | Q9NW15 | |
| LSGYKSLTSLPCYQH | 501 | Q9BY79 | |
| YFCPVLATGLSALYS | 256 | Q8N612 | |
| SGSHLTPLCYSFISY | 1201 | Q9NVI1 | |
| CTLPSDINVGSYNIY | 41 | A0A075B6J1 | |
| LAPLSTTYVGFCVYA | 346 | P53985 | |
| SSALIVSLPYLNSGY | 301 | O00476 | |
| VSLPYLNSGYITATA | 306 | O00476 | |
| EGSYLSSYPTCPAQA | 236 | Q6ISU1 | |
| LQYGCTSFIYLSPSS | 251 | Q8NGI7 | |
| TISSLQPEDIATYYC | 96 | P01593 | |
| EAQSCYSLGNTYTLL | 281 | P81274 | |
| YPCLQVYVNLTSSGE | 111 | Q9Y691 | |
| TSPSGNILEYSAYLA | 701 | Q9Y5Z7 | |
| VYTPTVGLACQQYSL | 101 | P48163 | |
| TYTLVTCLGLSYDGL | 176 | P43358 | |
| SPLTICYPEYTGSNT | 281 | P08754 | |
| RCSSASPAGDSLSYY | 16 | P01100 | |
| SGYQTTLALGPLYES | 276 | Q5MY95 | |
| YSYLCTEPENVTNGT | 46 | Q8N370 | |
| SYFSAPNSYLTGCTE | 376 | Q9HCE5 | |
| DYSGTYTVKLVPCTA | 2806 | Q5SZK8 | |
| YSTKPGSYIFRLSCT | 276 | Q13191 | |
| ETCLAPELYNGNYST | 151 | P05160 | |
| DQAPYTVCNSSLSEY | 696 | Q9ULD0 | |
| TIPSQGSDYDCYSVN | 486 | Q765P7 | |
| GTLPYSYNLCVASQS | 746 | Q9Y5G2 | |
| SNLYSAPTSCQGRCY | 81 | P21128 | |
| LYYCASRQGTGSPAA | 261 | Q8IX07 | |
| PYSYCNTTLDQIGTC | 36 | Q13324 | |
| GCSSSSSYPAQISYL | 81 | Q6UWN0 | |
| YLLPAVESTTYSGCT | 151 | Q71SY5 | |
| AAYAPGATYSTDCTN | 401 | P98088 | |
| SYCYGNDSASLGALP | 5231 | P98088 | |
| AYLPSVDYAICSSSS | 166 | Q9UNI1 | |
| PLASYLGYTVNSATA | 431 | P56199 | |
| YSTPSGYLELTDSCQ | 911 | Q3BBV0 | |
| YGELTYSIVSPCFLT | 2801 | Q6V1P9 | |
| FGSPYLACYSLSVTI | 46 | Q9UBM1 | |
| SCETSSQDLGFSYYP | 56 | Q8WUB8 | |
| APYTVCNSSLSEYGV | 711 | Q02218 | |
| YCGNSFPLNYSSIVG | 1811 | O60494 | |
| PGLNYCTSGAYSNAS | 971 | P04114 | |
| YFCPVLATGLSGLYS | 241 | Q05DH4 | |
| GLSVTYSCESGYLLV | 176 | P20023 | |
| GLSSPQLCPATATYY | 31 | Q14209 | |
| SSCLYFIYVAPGIAN | 26 | Q9UBX8 | |
| SLSCYAASNPPAQYS | 256 | P13688 | |
| LVSYTPAYLEGSCKD | 71 | Q9UKT4 | |
| PLGSLHCQSYYQSLS | 311 | Q8NFW5 | |
| SPYQLIYHSSTACLS | 221 | Q8ND61 | |
| GIYTTSSPEACQYIA | 186 | Q96GR2 | |
| SCLQYYTGPSNATAG | 726 | O60266 | |
| ENQPYSYCLLSGSLG | 126 | Q9BY19 | |
| AYEPQIGYCISASTL | 301 | O43462 | |
| YGTRSPECISYTNSL | 936 | Q12840 | |
| TISSLQPEDIATYYC | 96 | P01594 | |
| CGSSYPSNLVYSTDL | 26 | Q3SY46 | |
| YSPNTCQLGSSLYNG | 36 | Q3LI76 | |
| SLYNGCQETYCEPTS | 46 | Q3LI76 | |
| LETSCGSSTAYYVPR | 76 | Q6PEX3 | |
| GSALCSYNLKPSEYT | 136 | Q8WWI5 | |
| ASAATSLITYLGLYP | 306 | O43174 | |
| NYSYPGSDSSLLINA | 406 | Q17RY0 | |
| YSPDGTYLAVGCNDS | 416 | Q05BV3 | |
| YPQYSCSTTGSSLNA | 191 | P22830 | |
| CALQVSPSGYYLDTE | 71 | Q9Y613 | |
| PDYLQYSISTALCSL | 306 | Q7L3B6 | |
| YLSCSADSNPPAQYS | 351 | P11464 | |
| RCYGSLSSNPYLLTH | 396 | Q8N6C8 | |
| CVYKGSLSSYGAVLP | 2526 | P98161 | |
| YGTVIGLYLCPSANS | 261 | P47887 | |
| PALQLGEGSYYLTTT | 816 | Q8TB24 | |
| ISSPLQAASIYGASY | 226 | P35548 | |
| SYQDVACYGTLPRDS | 1421 | Q9H1H9 | |
| YYKLVTCDLSSQSSP | 396 | Q8N2Y8 | |
| EGSCYTSLISDICYP | 101 | Q16799 | |
| YSSGILTAVLPCLAY | 296 | Q08AM6 | |
| PLYDGNSSVCSTADY | 956 | P35499 | |
| RCYGSLSSNPYLLSH | 396 | O75019 | |
| RCYGSQSSKPYLLTH | 396 | Q8NHL6 | |
| TFLAYDQPTISYCGV | 521 | Q86VH5 | |
| YSTPSVYLGLTDSCQ | 911 | Q5TAG4 | |
| LQDSLGRCYSTPSGY | 686 | Q5TI25 | |
| PYDNLCYLVTIFTGS | 1226 | Q9NTG1 | |
| YLSCSADSNPPAQYS | 351 | Q9UQ74 | |
| TICSNYTSLGLSSYP | 996 | Q13635 | |
| TAYSSCRLDTPNSYG | 256 | Q9UPS6 | |
| CGPYTTSDSITYDPL | 346 | Q14181 | |
| TASYSCDTGYSLQGP | 1926 | Q4LDE5 | |
| LAYLSTALYTCKPGF | 2456 | Q4LDE5 | |
| LSIYDNVPGSILYSS | 876 | Q96QB1 | |
| YSGLNGNPSSELDYC | 321 | O94875 | |
| GNPSSELDYCSTYRQ | 326 | O94875 | |
| RISNITPADAGTYYC | 106 | Q5TFQ8 | |
| ITCSYKASSGLLYPL | 341 | Q08945 | |
| TLCSNGVLTYYSSLG | 306 | A6NIR3 | |
| LQCESSSGTEPIVYY | 151 | Q9H6B4 | |
| SVIYDQLCSVPSYSI | 226 | Q9BXN2 | |
| SKSYYLCTSLSTPAL | 186 | Q9H8M5 | |
| LCYLPGNSKCSSVYE | 411 | Q6S5L8 | |
| SISNITPADAGTYYC | 106 | O00241 | |
| CAAAYALVSNLSPYS | 486 | O00562 | |
| LATCSALGYLEGDTY | 11 | Q9UNS1 | |
| YNEYCTLTQDSLPIT | 96 | Q5GAN3 | |
| QSVGPDSCYILTAYQ | 556 | Q5T7W0 | |
| CYATPSSNATDPLKY | 506 | P07911 | |
| GYLSSPQSITDTCLY | 271 | Q5K4L6 | |
| AFLTINCTYTATGYP | 36 | A0A087WT02 | |
| YNLPYAAGLSSTAIV | 1381 | O15014 | |
| SPPGLIVTSYSNYCE | 96 | Q9BY14 | |
| NSAEGEYSALCSYLS | 1531 | Q8IWV7 | |
| EYSALCSYLSLPTNL | 1536 | Q8IWV7 | |
| ACLPATSYLLTYLSS | 146 | Q96DC7 | |
| LYIQNYTSAVPGTCL | 341 | Q96L92 | |
| QGNCTFSYLESITPY | 1736 | Q86WI1 | |
| CYSKDGLYASLTTLP | 831 | Q9ULM0 | |
| PSVQLSDSAVYYCAL | 96 | A0A075B6X5 | |
| DLSTTYCGSAAYASP | 166 | Q9BXA6 | |
| AYGPVSSSLYDLTNV | 381 | Q8NET8 | |
| CLAFSSSGPQSQTYY | 601 | O60346 | |
| KYGCYSSLPVASQGL | 201 | Q8N6G2 | |
| EEGYCLTSLQSALSY | 606 | Q9Y2B5 | |
| SGFPYGVTNNCLSYL | 111 | O75604 | |
| TLQGLYQTASCPEYL | 181 | O75604 | |
| LCYIDSQTDGGIPSY | 506 | Q5TAX3 | |
| NLSVDNCSPYLGSYS | 1636 | Q6N021 | |
| SGYINSTDTSYLPQC | 106 | P01266 | |
| EPLSGLYTCTLSYKT | 101 | Q6X784 | |
| PGSSVVLEATYSSCY | 81 | Q12836 | |
| CGSLYTVLEEPSNAY | 91 | Q9UHD2 | |
| SFLSYINTSAEPLYG | 701 | O75382 | |
| EPSFTCASDGLTYYN | 141 | Q8TEU8 | |
| YSSDLYLALAQPGVS | 241 | Q8N145 |